Abstract-Many members of the two-pore-domain potassium (K ϩ ) channel family have been detected in the mammalian heart but the endogenous correlates of these channels still have to be identified. We investigated whether I KAA , a background K ϩ current activated by negative pressure (stretch) and by arachidonic acid (AA) and sensitive to intracellular acidification, could be the native correlate of TREK-1 in adult rat atrial cells. Using the inside-out configuration of the patch-clamp technique, we found that I KAA , like TREK-1, was outwardly rectifying in physiological K ϩ conditions, with a conductance of 41 pS at ϩ50 mV. Like TREK-1, I KAA was reversibly activated by clinical concentrations of volatile anesthetics (in mmol/L, chloroform 0.18, halothane 0.11, and isoflurane 0.69). In cell-attached experiments, I KAA was inhibited by chlorophenylthio-cAMP (500 mol/L) and also by stimulation of ␤-adrenergic receptors with isoproterenol (1 mol/L). In addition, TREK-1 mRNAs were detected in all cardiac tissues, and the TREK-1 protein was immunolocalized in isolated atrial myocytes. Such a background potassium channel might contribute to the positive inotropic effects produced by ␤-adrenergic stimulation of the heart. It might also be involved in the regulation of the atrial natriuretic peptide secretion. (Circ Res. 2001;89:336-342.)
C ardiac potassium (K ϩ ) channels have extensively been studied for years. In the working atrial and ventricular myocytes, they belong to the following two major families: (1) the voltage-dependent channels (I to , I Kr , I Ks , etc), which are involved in the different repolarization phases of the cardiac action potential (AP), and (2) the background K ϩ channels, which stabilize the resting membrane potential at a hyperpolarized level and regulate AP duration in physiological conditions (I K1 ), during sympathetic stimulation of the heart (I KACh ), or during pathological events such as ischemia (I KATP , etc) (for a review, see Carmeliet 1 ) .
During the last decade, a large number of K ϩ channel ␣ subunits were cloned and further characterized in expression systems such as Xenopus oocytes and mammalian cell lines (COS, HEK, etc). Some of these cloned channels were proposed as molecular substrates for the endogenous cardiac K ϩ currents on the basis of their biophysical and pharmacological properties. For instance, Kv4.2 is suggested to be a molecular correlate of I to , whereas HERG and KvLQT1/Isk correspond to I Kr and I Ks , respectively. 2-6 IRK1 (Kir2.1) generates a current similar to that of I K1 , whereas GIRK1 (Kir3.1) forms a complex with GIRK4 (Kir3.4) to reproduce I KACh . 7, 8 Kir6.2 coassembles with the sulfonylurea receptor SUR2A to reconstitute the cardiac K ATP channel. 9, 10 However, not all cloned K ϩ channel ␣ subunits shown to be expressed in the heart have been associated with an endogenous channel. This is particularly the case for the expanding family of mammalian two-pore-domain potassium (K 2P ) channels. 11 Of the 11 functional members that have now been cloned, the following seven were detected in the mammalian heart, at low or high levels, by Northern and reverse transcriptase-polymerase chain reaction (RT-PCR) experiments: TWIK-1 (human), TWIK-2 (human and rat), TREK-1 (mouse), TASK-1 (human, mouse, and rat), TASK-3 (rat), THIK-1 (rat), and TALK-2 (human). [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] TREK-1 is one of the most interesting members of the K 2P channel family. It is activated by changes in membrane tension (stretch), by arachidonic acid (AA) and other polyunsaturated fatty acids, and by intracellular acidification. 15, 24, 25 It looks similar to a background potassium channel that was previously recorded in adult rat atrial myocytes. 26 This channel, also sensitive to intracellular acidosis and activated by stretch, produces an outwardly rectifying current, named I KAA , on application of AA. Despite the lack of specific effectors for TREK-1, this K 2P channel presents an interesting property; it is activated by volatile anesthetics, 27 whereas all cardiac potassium channels studied until now are either inhibited or not sensitive to these agents (I to , 28 I K , 29 -31 I K1 , 32 and I KATP , 33, 34 with the exception of I KACh , which is activated by halothane. 35 The purpose of this work is to establish the presence of the TREK-1 protein in the heart using specific antibodies to demonstrate that TREK-1 is the channel responsible for I KAA and that I KAA , like TREK-1, 24,27 is activated by clinical concentrations of volatile anesthetics and is inhibited by increases of cAMP that activate protein kinase A (PKA) and that can be triggered by ␤-adrenergic stimulation.
Materials and Methods

Cell Isolation
Male Wistar rats (200 to 300 g) were anesthetized by intraperitoneal injection of sodium pentobarbital (90 mgϫkg Ϫ1 ). Heart dissociation was performed following a previously described protocol. 33 Oxygenated bicarbonate-buffered solution, mixed with 0.06% collagenase (type II, Worthington) and 0.03% hyaluronidase (type IV-S, Sigma) for 20 to 45 minutes and containing the following, was used (in mmol/L): NaCl 125, KCl 5, MgSO 4 
Electrophysiological Experiments
Whole-cell, inside-out, and cell-attached configurations of the patchclamp technique were performed on atrial cells at room temperature (20°C to 22°C) with a RK300 patch-clamp amplifier (Bio-Logic). Pipettes (3 to 5 M⍀) were Sylgard-coated when used for singlechannel experiments. The standard intracellular solution contained the following (in mmol/L): KCl 150, MgCl 2 2, EGTA 5, and HEPES 10 (pH adjusted to 7.2 with KOH). For cell-attached experiments, the same solution without EGTA was used as bathing solution. The basic extracellular solution contained the following (in mmol/L): NaCl 145, KCl 5, MgSO 4 2, and HEPES 10 (pH adjusted to 7.2 with NaOH). AA, lysophosphatidylcholine (LPC), chlorophenylthiocAMP (CPT-cAMP), glibenclamide, and tetraethylammonium (TEA) were all purchased from Sigma-Aldrich Chimie. The solutions containing volatile anesthetics were prepared as previously described. 27 Negative pressure was applied to the pipette via a calibrated syringe. Whole-cell recordings were digitized and analyzed with pClamp software. Single-channel recordings, filtered at 3 kHz, were digitized using a DAT recorder (Bio-Logic) and further analyzed with Biopatch software (Bio-Logic). Maximum open probabilities of a single channel (P Omax , measured over 5 seconds every 20 or 30 seconds, during a burst of openings) and amplitude histograms were determined using filtered signals at 1 kHz. Results, expressed as meanϮSEM, were considered as significant when PϽ0.05 with the Student t test.
Reverse Transcriptase-Polymerase Chain Reaction
Adult rat hearts were dissected, and total RNAs from four different tissues (atrium, septum, left ventricle, and right ventricle) were extracted by the guanidinium isothiocyanate method. Five micrograms of RNA was reverse transcribed in a final volume of 40 L. In a first step, these cDNAs were used as template for PCR by using primers deduced from the mouse TREK-1 sequence, as follows: sense primer, 5Ј-TCAAGCACATAGAAGGCTGG-3Ј, and reverse primer, 5Ј-TCAGGTGGTTCACAGACAGG-3Ј. The amplified DNA corresponding to rat TREK-1 DNA was subcloned and then sequenced. The deduced proteic sequence represents 100% identity with mouse TREK-1 over 145 amino acids. In a second step, the following two rat-specific primers were deduced from this sequence and used for PCR amplification: sense primer, 5Ј-GCCCTGGACGCCATCTAC-3Ј, and reverse primer, 5Ј-GTTACCCGCCAGCTCTGCA-3Ј. One microliter of each sample was used as template. PCR conditions were 32 cycles of 30 seconds at 94°C, 30 seconds at 60°C, and 30 seconds at 72°C. The amplified fragments were transferred onto nylon membrane and probed with a 32 P-labeled internal primer specific for TREK-1, 5Ј-GGATTTGGCGATTATGTGGCA-3Ј. For control, actin was amplified and analyzed according to the same protocol.
Membrane Preparations and Western Blot
Rat ventricular and atrial microsomes were prepared from adult rats. 36, 37 Tissues were minced and homogenized, and nuclei and debris were pelleted by centrifugation at 1000g. The supernatant was then centrifuged (8000g for 20 minutes), and again the supernatant was recovered and then treated with 0.5 mol/L KCl (4°C for 30 minutes). Microsomes were recovered after centrifugation (60 000g for 30 minutes). Homogenates of COS-7-transfected cells were prepared as previously described. 38 Aliquots of solubilized ventricular and atrial microsomes (25 g) and COS-7-transfected cell homogenates (5 g) were fractionated on 10% SDS-PAGE gels and subjected to Western blotting. Immunoblot analysis was performed as described previously, using rabbit polyclonal antibodies directed against TREK-1. 38 
Immunohistochemistry
Immunohistochemical studies were performed on freshly isolated adult rat atrial myocytes. Cells were plated on two-chamber Falcon culture slides and fixed with 4% paraformaldehyde in PBS. Cells were permeabilized in 0.3% Triton X-100 for 15 minutes and then incubated in blocking buffer (5% normal goat serum and 0.05% Triton X-100 in PBS) (3 hours at room temperature). Cells were hereafter incubated with TREK-1 antibodies (1:3000 to 1:5000) 38 at 4°C overnight. Development was performed using either the biotinylated horseradish peroxidase-diaminobenzidine (DAB) method (Vectastain Elite ABC kit, Vector Laboratories) or the Alexa Fluor 488 goat anti-rabbit IgG antibody (Molecular Probes).
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results
Voltage-Clamp Recording of a Potassium Current Activated by Chloroform
To our knowledge, among all K ϩ channels that have been detected by molecular biology techniques in the heart, TREK-1 is the only one to be activated by chloroform. We used this property to investigate the possible presence of a TREK-1-like potassium current in adult rat atrial cells. Voltage-clamp experiments were performed using a protocol with two depolarizing steps ( Figure 1A ). The current recorded at Ϫ40 mV was rapidly increased by chloroform (0.18 mmol/L), whereas both peak and steady-state outward currents at ϩ40 mV were inhibited. This initial inhibition at ϩ40 mV is probably due to an effect on voltage-dependent potassium channels, as already reported for halothane in other preparations. 28, 29, 39 When chloroform application was maintained, a noninactivating outward current finally developed at ϩ40 mV. This current, not sensitive to 10 mol/L glibenclamide, was mainly carried by potassium ions as indicated by the reversal potential (Ϫ80 mV in this example) of the current-voltage curve obtained under chloroform ( Figure 1B) . Chloroform effects were completely reversible and reproduced in five other cells. Isoflurane (0.69 mmol/L) also produced a strong increase of a similar noninactivating potassium current (nϭ3, not shown).
Identification of I KAA
In inside-out patches, we first used negative pressure (stretch) and AA stimulation to confirm the presence of I KAA . 26 In physiological K ϩ conditions, stretch (PϷ12 mm Hg) instantaneously activated a channel (Figure 2A ) characterized by a
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flickering behavior and bursting openings, with a mean open time of 1.63Ϯ0.18 ms at ϩ40 mV (nϭ4). This channel was not voltage-sensitive from Ϫ10 to ϩ40 mV. In the particular recording shown in Figure 1 , the maximum open probability (P Omax ) averaged over six different voltages was 0.36Ϯ0.01. Channel activity was not affected by 10 mol/L glibenclamide or by 10 mmol/L TEA, a blocker for K ATP and voltage-sensitive K ϩ channels, respectively, and it was not calcium-dependent, as we used calcium-free extracellular solutions in addition to the presence of a calcium chelator (EGTA, 5 mmol/L) in intracellular solutions. AA (10 mol/L) applied to the cytosolic surface of the patch was able to activate the channel with a low activity remaining after washout of the fatty acid ( Figure 2B ). The corresponding current-voltage curves were outwardly rectifying both in physiological and in symmetrical K ϩ conditions, with chord conductances at ϩ50 mV of 41Ϯ1 pS (nϭ4) and 118Ϯ4 pS (nϭ3), respectively ( Figure 2C ).
Volatile Anesthetics Activate I KAA
The 41-pS conductance of I KAA in physiological K ϩ conditions is close to the 48-pS conductance previously measured for TREK-1 expressed in COS cells. 24 To further demonstrate that TREK-1 generates I KAA , we first examined the effect of three volatile anesthetics that are known to activate TREK-1 27 (chloroform, halothane, and isoflurane) on the native cardiac channel in the inside-out configuration. Chloroform (0.18 mmol/L), applied to the cytosolic side of the patch, activated a channel ( Figure 3A ) with a P Omax (calculated from amplitude histograms in Figure 3B ) of 0.33Ϯ0.04 (at 0 mV, nϭ3) ( Figure 3C ). Chloroform-induced openings occurred in bursts (mean open time of 1.6 ms in this example) and were highly flickering as shown in Figure 3D (inset). This chloroform-activated current did not display voltage sensitivity from Ϫ10 to ϩ40 mV, as indicated by the P Omax of 0.36Ϯ0.01 averaged over this voltage range. The currentvoltage curve established under chloroform ( Figure 3D ) was perfectly superimposable on the one obtained under AA and stretch. Channel activity was significantly reduced after chloroform washout ( Figures 3A and 3C) , but it was then always possible to reactivate the channel with stretch. As illustrated in Figure 4A , halothane (0.11 mmol/L) was also able to induce bursting openings but only when the channel had been preactivated (P Omax ϭ0.13Ϯ0.02 versus P Omax ϭ0.03Ϯ 0.01 in control conditions, at 0 mV, nϭ3, PϽ0.05). Isoflurane (0.69 mmol/L) activated the channel in the same way as chloroform ( Figure 4B) ; P Omax ϭ0.26Ϯ0.04 versus P Omax ϭ0.01Ϯ 0.01 in control conditions (at 0 mV, nϭ3, PϽ0.05). The current-voltage curves of isoflurane-and chloroform-induced currents were perfectly superimposable and also superimposable to the current-voltage curves obtained after activation by AA and stretch. Washout of the isoflurane-induced effects was rapid (Figure 4C ), and the channel could then be reactivated by stretch. 
I KAA Is Regulated by the PKA-Dependent Pathway
TREK-1 is potently inhibited by intracellular increases of cAMP via a PKA activation that leads to a phosphorylation of a well-identified serine residue situated in the cytoplasmic C-terminal region. 24 We investigated whether I KAA could also be regulated by cAMP. Spontaneous channel activity was never recorded in cell-attached experiments. Therefore, the analysis of cAMP effects was first carried out after application of AA. When I KAA was activated by AA (10 mol/L) ( Figure 5 ), additional application of 500 mol/L CPT-cAMP, a permeant analog of cAMP, fully inhibited channel activity within 1.5 to 2 minutes (nϭ3). We then examined whether CPT-cAMP could regulate I KAA when it had been induced by chloroform. Extracellular application of 0.18 mmol/L chloroform activated the same flickering current (P Omax ϭ0.14Ϯ0.01 at 0 mV, nϭ4) as AA, an effect that was again inhibited ( Figure 6A ) after a 1.5-to 2-minute application of CPTcAMP ( Figure 6B ). We also recorded the CPT-cAMP inhibition of I KAA after activation of this current by stretch (PϷ12 mm Hg, nϭ2, not shown). Because in cardiac cells cAMP is produced by adenylate cyclase from cytosolic ATP, as a result of ␤-adrenergic stimulation, we tested whether the inhibition of I KAA could be produced by stimulation with isoproterenol, a specific agonist of ␤-adrenergic receptors. In cell-attached experiments, extracellular application of isoproterenol (1 mol/L) strongly inhibited the AA-induced current within 14.2Ϯ0.7 seconds (nϭ4) (Figures 7A and 7B ).
TREK-1 Is Expressed in Cardiac Preparations
RT-PCR techniques indicate that the mRNA for TREK-1 was present in atria and ventricles as well as in the septum of adult rat heart ( Figure 8A ). To determine whether TREK-1 proteins could also be detected, rat ventricular and atrial microsomes were separated on SDS polyacrylamide gels and immunoblotted with affinity-purified polyclonal anti-TREK-1 antibodies. Figure 8B shows that the anti-TREK-1 antibody recognizes a single band at Ϸ45 kDa, which is the same size as that obtained in membranes from TREK-1-transfected COS cells that express this channel at a high level in their plasma membrane. 24 The presence of TREK-1 in the plasma membrane was confirmed in a second set of experiments in which isolated atrial myocytes, the same preparation used in parallel for electrophysiology, were fixed and immunostained with anti-TREK-1 antibodies. Figure 8C illustrates typical experiments, showing the staining of atrial cells (a and c). No labeling was seen in atrial cells subjected to the same staining protocols, except that the primary antibody was omitted (b).
Discussion
This work provides biophysical and pharmacological evidence indicating that I KAA , the atrial background potassium current activated by membrane tension (stretch) and by AA, 26 is probably generated by the TREK-1 channel or a very closely related member of the K 2P channel family, as follows.
(1) I KAA in symmetrical K ϩ conditions has a single-channel 
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conductance of 118 pS, close to the 101 pS measured for TREK-1 in COS cells. 24 (2) Both the native channel that generates I KAA and the TREK-1 channel are activated by stretch and by AA. 15, 24, 26 Moreover, in physiological K ϩ conditions, the resulting current is outwardly rectifying in both cases ( Figure 1C and Patel et al 24 ) , and conductances are also very similar, 41 pS for I KAA and 48 pS for TREK-1 (in COS cells 24 ) . (3) Neither I KAA nor the current generated by TREK-1 in a heterologous system is sensitive to voltage in physiological K ϩ conditions. Both the native channel and TREK-1 display flickering openings occurring in bursts as long as the stimulus is maintained. (4) Both the native currents corresponding to I KAA and to TREK-1 are sensitive to intracellular acidification, 25, 26 and in both cases decreasing pH i leads to an increase in stretch sensitivity. (5) TREK-1 is potently activated by LPC 40 ; similarly, we have demonstrated in cell-attached experiments an activation of I KAA with extracellular application of 10 mol/L LPC (nϭ3, not shown). (6) Neither I KAA nor TREK-1 15 is inhibited by glibenclamide or TEA or is Ca 2ϩ -sensitive. None of the other cloned K 2P channels, demonstrated to be present in the heart and analyzed for their biophysical and pharmacological properties, 12,14,16,20 -23 display characteristics as close to I KAA as do those of TREK-1. 24 The only difference is the stretch sensitivity (P 1/2 ϭϪ12 mm Hg for I KAA 26 and P 1/2 ϭϪ23 mm Hg for I TREK-1 ). The most probable interpretation of this difference between the native and the cloned channel is that there are additional subunits that associate with the TREK-1 protein to modify its sensitivity to pressure just as ␤-type subunits change the voltage sensitivity (and/or kinetics) of voltage-sensitive K ϩ channels and the Ca 2ϩ sensitivity of K Ca2ϩ channels. Another key element indicating the TREK-1 nature of I KAA is provided by its unique sensitivity to volatile anesthetics. The activity of several of the K 2P channels that have been shown to be present in the heart is modified by volatile anesthetics but in a different way. TASK-1 is not sensitive to chloroform but is activated by halothane and isoflurane. 27 TWIK-2 is inhibited by chloroform and by halothane. 14 THIK-1 is not sensitive to chloroform and is inhibited by halothane. 22 TALK-2 is inhibited by chloroform and by halothane but is slightly activated by isoflurane. 23 Among the K 2P channels present in the heart, only TREK-1 activity is increased by chloroform, halothane, and isoflurane. 27 In inside-out experiments, we have found that I KAA was also reversibly activated by clinical concentrations of (in mmol/L) chloroform 0.18, halothane 0.11, and isoflurane 0.69. This indicates, as also previously observed for TREK-1, 27 that these anesthetics do not exert their effect via secondmessenger molecules but rather directly on the channel macromolecule.
In addition to its sensitivity to volatile anesthetics, TREK-1 is inhibited by cAMP via PKA phosphorylation of Ser333 in the C-terminal part of the channel structure. 24 The native cardiac channel generating I KAA can also be regulated by cAMP. In cell-attached experiments, CPT-cAMP, the permeant analog of cAMP, produced a complete inhibition of I KAA when the current had been activated by either AA (Figure 4) , chloroform ( Figure  5 ), or stretch. Interestingly, the same inhibitory effect was observed after stimulation of the atrial-cell ␤-adrenergic receptors with the specific agonist isoproterenol, a treatment that is known to increase the intracellular cAMP content.
All of these results taken together provide very strong evidence that I KAA is the endogenous correlate of TREK-1 in adult rat atrial myocytes. In addition, RT-PCR, Western blot, and immunohistochemistry experiments independently demonstrate the presence of TREK-1 in adult rat heart. The mechanosensitive I KAA channel is also present in ventricular cells with a singlechannel conductance of 106Ϯ12 pS at ϩ60 mV and 72Ϯ10 pS at Ϫ60 mV and the same pressure and pH sensitivity as the atrial channel. 26 The mechanism of regulation of this ventricular I KAA channel via AA production was recently analyzed. 41 In the adult human heart, the expression of TREK-1 is much less important than in rodent heart but it could be significantly upregulated during development or in aging and/or heart diseases.
In the working atrial and ventricular myocytes, the main background K ϩ current is generally considered to be carried by the inwardly rectifying current I K1 . Under physiological conditions, it stabilizes the resting membrane potential near the K ϩ equilibrium and participates in the final repolarization phase of the AP. I TREK-1 , as an outwardly rectifying current, will balance any membrane depolarization and will contribute to the regulation of the AP duration. Because of its stretch sensitivity, we suggest that this current could be a negative feedback after stretch activation of nonselective cationic channels. 42 TREK-1 would then have a beat-to-beat regulation of atrial function. It is particularly interesting to note that both I K1 43 and I TREK-1 (the present study) are inhibited by the specific ␤-adrenergic agonist isoproterenol via a phosphorylation process involving cAMPdependent kinase. Then, the positive inotropic effect exerted by ␤-adrenergic agonists on the heart will not only be produced by activation of voltage-dependent Ca 2ϩ channels but will also be the result of prolonged Ca 2ϩ entry into the cell by inhibition of I K1 and I TREK-1 activities.
Because I TREK-1 is present in atrial cell and is activated by physiological levels of stretch, it might be involved in the regulation of atrial natriuretic peptide (ANP) secretion. Stretch is known to be the main stimulus eliciting this secretion (for a review, see Ruskoaho 44 ) which plays an important role in the control of blood pressure. The initial depolarization process associated with the intracellular Ca 2ϩ increase that is necessary for ANP secretion is expected to be triggered by stretch activation of nonselective stretch-activated cationic channels. 42 Half-maximal activation of these cationic channels occurs for a pressure of 1.5 mm Hg, whereas it occurs Ϸ12 mm Hg for the K ϩ channel I KAA . 26 This suggests that a significant activation of I TREK-1 by stretch can only occur secondary to the activation of these cationic channels. The function of TREK-1 could then be to act as a negative feedback for ANP secretion, and a ␤-adrenergic stimulation inhibiting TREK-1 could then be expected to enhance ANP release from atrial myocytes, an effect that has indeed been observed. 44 
